A Grand Rapids molecular research lab is closing in on a nationwide
launch date for a prenatal genetic test for Down syndrome. The company
says it hopes to expand its research lab in the Grand Rapids area.
According to excerpts from the story:
The Sequenom Center for Molecular
Medicine is leasing additional office space in downtown Grand Rapids as
it prepares to bring its first prenatal genetic test to the national
market.
The molecular diagnostics lab, acquired last year by
San Diego-based Sequenom Inc. from the Van Andel Institute and Spectrum
Health, recently leased 5,423 square feet of office space in the Arena
Station building on Ottawa Avenue. The company is developing genetic prenatal diagnostic tests to screen for genetic disorders and birth defects.
Read the complete story here.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.